Healthcare provider profile · identity verified

Edward Supinski, MD

Internal Medicine · PORT ORANGE, FL · NPI 1700854833

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	758	217
Amlodipine Besylate	Amlodipine Besylate	552	174
Rosuvastatin Calcium	Rosuvastatin Calcium	445	137
Levothyroxine Sodium	Levothyroxine Sodium	358	102
Lisinopril	Lisinopril	336	106
Omeprazole	Omeprazole	314	95
Losartan Potassium	Losartan Potassium	247	78
Eliquis	Apixaban	226	59
Metoprolol Tartrate	Metoprolol Tartrate	213	63
Metoprolol Succinate	Metoprolol Succinate	183	55
Potassium Chloride	Potassium Chloride	183	60
Metformin Hcl	Metformin Hcl	180	57
Trazodone Hcl	Trazodone Hcl	171	59
Tamsulosin Hcl	Tamsulosin Hcl	163	51
Hydrochlorothiazide	Hydrochlorothiazide	156	50
Simvastatin	Simvastatin	155	48
Pantoprazole Sodium	Pantoprazole Sodium	153	56
Furosemide	Furosemide	148	50
Gabapentin	Gabapentin	140	46
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	138	45
Alprazolam	Alprazolam	123	25
Carvedilol	Carvedilol	118	32
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	114	32
Fluticasone Propionate	Fluticasone Propionate	114	56
Albuterol Sulfate Hfa	Albuterol Sulfate	109	44
Pravastatin Sodium	Pravastatin Sodium	105	36
Atenolol	Atenolol	104	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	32
Allopurinol	Allopurinol	98	26
Alendronate Sodium	Alendronate Sodium	96	31
Doxazosin Mesylate	Doxazosin Mesylate	96	28
Zolpidem Tartrate	Zolpidem Tartrate	96	17
Ezetimibe	Ezetimibe	95	30
Jardiance	Empagliflozin	93	27
Meloxicam	Meloxicam	90	34
Finasteride	Finasteride	85	19
Mounjaro	Tirzepatide	83	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	20
Sildenafil Citrate	Sildenafil Citrate	79	17
Clopidogrel	Clopidogrel Bisulfate	78	25
Sertraline Hcl	Sertraline Hcl	78	26
Fluoxetine Hcl	Fluoxetine Hcl	72	20
Lovastatin	Lovastatin	70	21
Temazepam	Temazepam	68	suppressed
Donepezil Hcl	Donepezil Hcl	62	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	25
Methylprednisolone	Methylprednisolone	59	44
Tramadol Hcl	Tramadol Hcl	57	17
Famotidine	Famotidine	53	18
Glimepiride	Glimepiride	47	14
Lorazepam	Lorazepam	47	14
Montelukast Sodium	Montelukast Sodium	46	14
Diclofenac Sodium	Diclofenac Sodium	45	29
Warfarin Sodium	Warfarin Sodium	45	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	37
Nortriptyline Hcl	Nortriptyline Hcl	42	13
Diazepam	Diazepam	40	suppressed
Metformin Hcl Er	Metformin Hcl	40	12
Spironolactone	Spironolactone	40	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	37
Prednisone	Prednisone	38	22
Ramipril	Ramipril	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	13
Mirtazapine	Mirtazapine	37	15
Baclofen	Baclofen	35	suppressed
Buspirone Hcl	Buspirone Hcl	35	16
Clonidine Hcl	Clonidine Hcl	35	17
Enalapril Maleate	Enalapril Maleate	34	12
Xarelto	Rivaroxaban	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	29
Doxycycline Hyclate	Doxycycline Hyclate	33	27
Dropsafe Prep Pads	Alcohol Antiseptic Pads	33	11
Memantine Hcl	Memantine Hcl	33	11
Valsartan	Valsartan	33	11
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Fenofibrate	Fenofibrate	31	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Azithromycin	Azithromycin	25	23
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Estradiol	Estradiol	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Linzess	Linaclotide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Clonazepam	Clonazepam	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Colchicine	Colchicine	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Lactulose	Lactulose	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metolazone	Metolazone	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Novolog	Insulin Aspart	14	suppressed
Ozempic	Semaglutide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Repatha Pushtronex	Evolocumab	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Glipizide	Glipizide	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error